Russell Investments Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-88
| Closed | -$7.14K | – | 3971 |
|
|
2025
Q1 | $7.14K | Sell |
88
-56
| -39% | -$4.54K | ﹤0.01% | 3296 |
|
|
2024
Q4 | $13K | Buy |
144
+125
| +658% | +$11.3K | ﹤0.01% | 3091 |
|
|
2024
Q3 | $1.88K | Sell |
19
-2
| -10% | -$198 | ﹤0.01% | 3389 |
|
|
2024
Q2 | $1.95K | Buy |
+21
| New | +$1.95K | ﹤0.01% | 3351 |
|
|
2018
Q2 | – | Sell |
-50,446
| Closed | -$4.43M | – | 2972 |
|
|
2018
Q1 | $4.43M | Sell |
50,446
-4,022
| -7% | -$353K | 0.01% | 1426 |
|
|
2017
Q4 | $4.7M | Buy |
54,468
+4,109
| +8% | +$354K | 0.01% | 1383 |
|
|
2017
Q3 | $4.36M | Buy |
50,359
+1,218
| +2% | +$105K | 0.01% | 1337 |
|
|
2017
Q2 | $3.79M | Buy |
49,141
+18,746
| +62% | +$1.45M | 0.01% | 1375 |
|
|
2017
Q1 | $2.11M | Buy |
30,395
+4,079
| +16% | +$283K | ﹤0.01% | 1735 |
|
|
2016
Q4 | $1.57M | Buy |
+26,316
| New | +$1.57M | ﹤0.01% | 1932 |
|